Dr. Kodati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Wall St
Ann Arbor, MI 48105Phone+1 734-764-4190
Summary
- Dr. Shilpa Kodati is an ophthalmologist in Bethesda, MD. She specializes in vitreoretinal surgery and uveitis and is experienced in uveitis, retina surgery, immunology, vitreoretinal disease, and retinal imaging.
Education & Training
- Baylor College of MedicineFellowship, Surgical Retina and Vitreous, 2017 - 2019
- National Institutes of Health Clinical CenterFellowship, Ocular Immunology/Uveitis, 2016 - 2017
- UPMC Medical EducationResidency, Ophthalmology, 2013 - 2016
- MetroWest Medical CenterInternship, Transitional Year, 2012 - 2013
- Imperial College London School of MedicineClass of 2008
Certifications & Licensure
- TX State Medical License 2017 - 2026
- MI State Medical License 2022 - 2025
- DC State Medical License 2020 - 2024
- PA State Medical License 2013 - 2024
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 46 citationsOcular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies.Carl W Noble, Sapna Gangaputra, Ian Thompson, Amy Yuan, Andrea B. Apolo
Ocular Immunology and Inflammation. 2020-08-17 - 2 citationsPractice patterns regarding regional corticosteroid treatment in noninfectious Uveitis: a survey study.Matthew McHarg, LeAnne Young, Natasha Kesav, Mehmet Yakin, H Nida Sen
Journal of Ophthalmic Inflammation and Infection. 2022-01-04 - 18 citationsGain-of-function mutations incause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH sy...Christina Torres Kozycki, Shilpa Kodati, Laryssa Huryn, Hongying Wang, Blake M Warner
Annals of the Rheumatic Diseases. 2022-10-01
Press Mentions
- First U.S. Patient Receives Autologous Stem Cell Therapy to Treat Dry AMDSeptember 2nd, 2022
- First US Patient Gets Autologous Stem Cell Therapy to Treat Dry AMDSeptember 1st, 2022
- ARVO Foundation Announces 2021 Mallinckrodt Uveitis Research Fellowship RecipientJanuary 21st, 2021
Professional Memberships
- Member
- Member
- American Uveitis SocietyMember
- The Association for Research in Vision and OphthalmologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: